Drug-eluting stents boost survival in patients with coronary stenosis

April 21, 2009 Diagnostic Imaging. Drug-eluting stents boost survival in patients with coronary stenosis By H.A. Abella Coronary artery stenosis patients age 65 and older have better survival chances when they are treated with drug-coated stents than with bare metal stents, according to findings of a study involving more than a quarter million Medicare recipients. The study, sponsored by the Agency for Healthcare Research and Quality and the American College of Cardiology, is the largest to date comparing the safety and effectiveness of drug-coated and bare metal stents. Its findings provide important new evidence for decision making by heart disease patients and their physicians, said AHRQ director Dr. Carolyn M. Clancy.

See full article and related articles at DiagnosticImaging.com

This article was republished with permission from CMPMedica, LLC